Why this call
Growth Drug Powers Pharma Giant
Exceptional revenue growth continues to attract investors
Strong monthly price momentum
Positive news cycle reinforces bull case
Weather forecast
Eli Lilly and Company (LLY) stock forecast
Sunny
Buy
Score 72/100 · Confidence 75%
The outlook is bright — conditions favour stepping in.
Weighed fromlive price action
Where it's headed
Eli Lilly and Company price targets
As of Nov 6, 2026, Tickerday rates Eli Lilly and Company (LLY) a Buy, score 72/100, with 75% confidence. Each target is measured from $1,368, the price that day.
Next week
$1,381
+1.0% from $1,368
Positive news flow around its key drugs could help the stock regain its recent highs in the coming days.
Next month
$1,422
+4.0% from $1,368
Continued execution on its growth strategy and strong market momentum could push the stock to new highs over the next month.
Next year
$1,573
+15.0% from $1,368
The company's dominant position in high-growth drug categories is expected to fuel significant earnings growth, justifying a higher stock price over the long term.
Under the hood
What the engine weighed
Six factors, scored 0–100 from live market and financial data — the same read Wall Street does, minus the jargon.
72Overall score
Valuation
25
The stock trades at a high premium, reflecting lofty growth expectations.
Growth
95
The company is delivering phenomenal, best-in-class revenue growth.
Profitability
90
Elite margins show the company is extremely efficient at turning sales into profit.
Momentum
85
The stock has been in a very strong uptrend over the past year.
Fin. health
55
The company's debt levels are somewhat elevated but manageable.
Sentiment
80
Recent news about a new distribution deal has been very positive.
Key numbers
as of Nov 6, 2026Size and price
Growth and profit
Risk and payout
The argument
Both sides of the sky
Every call has a case against it. Here's the honest version of both.
The bull case
- Explosive revenue growth of over 45% is exceptional for a company of its size.
- Highly profitable, with net margins over 31%, turning a large portion of sales into profit.
- Strong price momentum, with the stock in a clear uptrend over the past year.
The bear case
- The stock trades at a high P/E ratio of 46.6, suggesting high expectations are already priced in.
- Debt levels are somewhat elevated, with a Debt-to-Equity ratio of 1.23.
- The stock price is near its 52-week high, which could make it vulnerable to pullbacks.
FAQ
Good questions
Tickerday's read of Eli Lilly and Company as of Nov 6, 2026: educational analysis, the same for everyone, not financial advice.
Most tools hand you the data.
Tickerday hands you the answer.
Now try yours
What about your stocks?
You just read Eli Lilly and Company. Type a company you own and get its call, and the why, in seconds. First one free, no account needed.
The receipts
Called it. Then it happened.
Real calls from the Tickerday engine, each one graded against the real price a month later.
Every call is graded
One month after the call, at the closing price.
Palantir Technologies Inc.
+52.3%
✓Called it
We said Buy at $122.33 on Jul 30. A month later the price was $186.29.
Graded Aug 28 at the closing price
Today's prices
Weather alerts
We'll watch the weather.You enjoy the day.
Save a stock to your Almanac. We'll track its forecast and let you know when the outlook changes.
Your Almanac
Watching 4 stocks
LLY
Eli Lilly and Company
Buy
AAPL
Apple
Buy
MSFT
Microsoft
Buy
TSLA
Tesla
Sell
9:41
Thursday, October 16
9:41
Nothing to chase. Nothing to refresh.
One blind call costs more
than a year of Tickerday.
Pricing
Start free, right here
Your first analysis is free, no account needed. Tickerday+ takes it from there.
Tickerday+
Pro
Built for fast clarity.
- Clear buy / hold / sell-style insights
- Key risks and opportunities
- Focused market analysis
- 40 priority credits every month
$9/mo
Billed monthly · ≈ $0.30/day
Tickerday+
Most popularPremium
The full why, explained.
- Expanded analysis & learning depth
- Interactive explanations & breakdowns
- Tap to understand key metrics & terms
- 100 priority credits every month
$228 (was)$169/yrSAVE 26%
Billed yearly · ≈ $14.08/mo≈ $0.46/day
Cancel anytime.
Get the full picture
That took thirty seconds.
Now imagine every stock you own.
You just understood LLY without reading a single chart. The Tickerday app does this for your whole watchlist — today's read whenever you want it, the full thesis, bull and bear scenarios with their odds — and wakes you the moment the weather turns.
One plain answer for every stock — Buy, Hold, or Sell
The full picture in seconds — thesis, targets & scenarios
Sleep easy — we watch the market and wake you if it turns
Free to download the day it lands — the web desk is open now
More forecasts
Head to head
More lists